Elevated GlycA concentrations have been shown to predict the risk of type 2 diabetes mellitus, cardiovascular disease, and all-cause mortality [15], and both GlycA and GlycB have been suggested to better reflect inflammation than traditional inflammatory markers such as C-reactive protein (CRP) and IL-6 [16,17]. This evidence concerns the gene CRP and diabetes mellitus.